These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8835713)

  • 1. Fluvoxamine and akathisia.
    Chong SA; Tan CH
    J Clin Psychopharmacol; 1996 Aug; 16(4):334-5. PubMed ID: 8835713
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient.
    Poyurovsky M; Meerovich I; Weizman A
    Int Clin Psychopharmacol; 1995 Jun; 10(2):111-4. PubMed ID: 7673653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine and tardive akathisia.
    Boffa E; Lofchy J
    Can J Psychiatry; 2000 Mar; 45(2):196. PubMed ID: 10742880
    [No Abstract]   [Full Text] [Related]  

  • 4. Sertraline and akathisia: spontaneous resolution.
    Olivera AO
    Biol Psychiatry; 1997 Jan; 41(2):241-2. PubMed ID: 9018398
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluvoxamine-Associated Galactorrhea: A Case Report.
    Chakladar A; Singh J; Tak NK; Patra BN; Sagar R
    J Clin Psychopharmacol; 2020; 40(1):101-102. PubMed ID: 31804454
    [No Abstract]   [Full Text] [Related]  

  • 6. Deliberate self-poisoning following fluvoxamine-neuroleptics combination.
    Chong SA; Cheong A
    J Clin Psychiatry; 1999 Dec; 60(12):869. PubMed ID: 10665638
    [No Abstract]   [Full Text] [Related]  

  • 7. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
    Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?
    Cheng YC; Huang MC
    Psychiatry Clin Neurosci; 2014 Mar; 68(3):244. PubMed ID: 24895743
    [No Abstract]   [Full Text] [Related]  

  • 9. Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.
    Vlatka BM; Branka AM; Branimir M
    Gen Hosp Psychiatry; 2010; 32(4):e9-e10. PubMed ID: 20633737
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor neonatal adaptation after in utero exposure to fluvoxamine.
    Kieviet N; Duijn M; Dolman KM; Honig A
    J Obstet Gynaecol; 2015 Feb; 35(2):201-2. PubMed ID: 25162141
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial.
    Shalbafan M; Malekpour F; Tadayon Najafabadi B; Ghamari K; Dastgheib SA; Mowla A; Shirazi E; Eftekhar Ardebili M; Ghazizadeh-Hashemi M; Akhondzadeh S
    J Psychopharmacol; 2019 Nov; 33(11):1407-1414. PubMed ID: 31575326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
    Pratheesh PJ; Praharaj SK; Srivastava A
    Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome and fluvoxamine: a case study.
    Bastani JB; Troester MM; Bastani AJ
    Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release fluvoxamine (Luvox CR).
    Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
    Denys D; van Megen HJ; Westenberg HG
    J Psychopharmacol; 2003 Mar; 17(1):127-9. PubMed ID: 12680750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?
    Ersche KD; Cumming P; Craig KJ; Müller U; Fineberg NA; Bullmore ET; Robbins TW
    J Psychopharmacol; 2012 Jun; 26(6):887-90. PubMed ID: 21746752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.
    Goodman WK; Kozak MJ; Liebowitz M; White KL
    Int Clin Psychopharmacol; 1996 Mar; 11(1):21-9. PubMed ID: 8732310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of fluvoxamine-mediated long QTU syndrome.
    Nia AM; Dahlem KM; Gassanov N; Hungerbühler H; Fuhr U; Er F
    Eur J Clin Pharmacol; 2012 Jan; 68(1):109-11. PubMed ID: 21713517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.